Related Experiment Video
Updated: Aug 10, 2026
09:32
Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method
Published on: September 10, 2017
p53 protein expression in cutaneous T-cell lymphomas
A F Lauritzen1, G L Vejlsgaard, K Hou-Jensen
1Department of Pathology, Herlev Hospital, University of Copenhagen, Denmark.
The British Journal of Dermatology
|July 1, 1995
Summary
Mutations in the p53 tumor suppressor gene are linked to high-grade cutaneous T-cell lymphomas (CTCL). Low-grade CTCL showed minimal p53 protein expression, suggesting p53 alterations are not critical in early-stage disease.
Area of Science:
- Oncology
- Molecular Biology
- Dermatology
Background:
- The p53 gene acts as a tumor suppressor, and its mutations are common in human cancers.
- Mutated p53 protein accumulates in cells, making it detectable via immunohistochemistry.
- Cutaneous T-cell lymphomas (CTCL) are a group of malignant skin conditions with varying grades of severity.
Purpose of the Study:
- To investigate the expression of p53 protein in different grades of cutaneous T-cell lymphomas (CTCL).
- To determine the potential role of p53 alterations in the pathogenesis of CTCL.
- To correlate p53 expression levels with lymphoma grade.
Main Methods:
- Utilized a monoclonal anti-p53 antibody (clone DO7) for immunohistochemical analysis.
- Examined p53 protein expression in 25 CTCL samples, including mycosis fungoides, Sézary's syndrome, and large cell lymphomas.
- Categorized lymphomas into low-grade and high-grade subtypes for comparative analysis.
Main Results:
- Easily detectable p53 protein was found in a significant proportion of neoplastic cells in half of the high-grade lymphomas.
- Low-grade lymphomas (mycosis fungoides, Sézary's syndrome) exhibited minimal to no p53-positive neoplastic cells.
- A clear distinction in p53 expression was observed between high-grade and low-grade CTCL subtypes.
Conclusions:
- Molecular and/or genetic alterations of p53 are likely involved in the development of high-grade CTCL.
- p53 gene alterations appear to play a minor role in the pathogenesis of low-grade CTCL.
- p53 protein expression levels can serve as a potential biomarker differentiating CTCL grades.
Related Concept Videos
01:23Negative Regulator Molecules
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
02:36DNA Damage can Stall the Cell Cycle
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:31The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...